ForCast Orthopedics and Koru Medical (KRMD) jointly announced an agreement leveraging Koru Medical’s FreedomEdge infusion system as part of ForCast’s technology platform for the treatment of periprosthetic joint infection.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KRMD:
- Strategic Growth and Innovation Drive Buy Rating for REPRO-MED Systems
- KORU Medical Systems Reports Strong Q2 2025 Growth
- REPRO-MED Systems: Strong Financial Performance and Strategic Growth Initiatives Drive Buy Rating
- Koru Medical price target raised to $4 from $3.50 at Piper Sandler
- KORU Medical Systems Reports Record Q2 2025 Results